Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study - Ahn, I. E., Farooqui, M. Z. H., Tian, X., Valdez, J., Sun, C., Soto, S., Lotter, J., Housel, S., Stetler-Stevenson, M., Yuan, C. M., Maric, I., Calvo, K. R., Nierman, P., Hughes, T. E., Saba, N. S., Marti, G. E., Pittaluga, S., Herman, S. E. M., Niemann, C. U., Pedersen, L. B., Geisler, C. H., Childs, R., Aue, G., Wiestner, A. (American Society of Hematology (ASH), 2018)
6266232